RACHEL KRAWCZYK: Open Payments
NPI 1285205948 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 25 payments from 16 companies in 2025. Trend: 2023 $1,004 · 2024 $697 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| SI-BONE, INC. | 1 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| ABBVIE INC. | 2 | $49 |
| Averitas Pharma Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $37 |
| Lundbeck LLC | 2 | $36 |
| Bioventus LLC | 1 | $34 |
Products named: RELISTOR, QUTENZA, HYQVIA, ACTHAR, FIRDAPSE, JOURNAVX, VYEPTI, DUROLANE.
Industry payments across NY — which companies pay providers there.
